[68Ga]Ga-FAPI-04 PET/MR 与 [18F]FDG PET/CT 在卵巢癌诊断准确性及可切除性预测中的对比研究
研究纳入30例临床高度怀疑卵巢恶性肿瘤患者,在5天内完成[18F]FDG PET/CT与[68Ga]Ga-FAPI-04 PET/MR,其中20例在完成[18F]FDG PET/CT后即刻行[18F]FDG PET/MR以进行一致性检验。结果显示两种方法在不同部位SUV-FDG无显著差异且诊断准确性相似,但[68Ga]Ga-FAPI-04 PET/MR在腹膜转移诊断中因SUV-FAPI更高而具优势,且膈肌转移预测不完全切除性的相关性最大(logistic回归 p=0.02)。
要点
- [68Ga]Ga-FAPI-04 PET/MR在腹膜转移诊断中因SUV-FAPI更高(p<0.01)而具优势。
- 膈肌转移与不完全切除性预测相关性最大(logistic回归 p=0.02)。
- SUVmax-FDG有助于评估肿瘤恶性程度,Ki67≥20%者SUVmax-FDG显著更高(p<0.05)。
核心结论
- [68Ga]Ga-FAPI-04 PET/MR在转移灶诊断方面具有明显优势,能更准确评估肿瘤负荷并预测不完全切除性。
- SUVmax-FDG有助于评估肿瘤恶性程度。
研究设计与样本
- 研究纳入2021年7月至2022年10月临床高度怀疑卵巢恶性肿瘤的30例患者,均行[18F]FDG PET/CT和[68Ga]Ga-FAPI-04 PET/MR检查,间隔在5天内。
- 其中20例在完成[18F]FDG PET/CT后即刻行[18F]FDG PET/MR以进行一致性检验。
- 图像分析比较SUV,并根据腹膜癌指数(PCI)和SUIDAN评分系统判断不完全切除性。
- 采用免疫组织化学染色分析FAP、HK2和Ki67的表达。
主要发现
- PET/MR与PET/CT在不同部位的SUV-FDG无显著差异(p>0.05),诊断准确性相似。
- [68Ga]Ga-FAPI-04 PET/MR在腹膜转移诊断中具优势,因SUV-FAPI更高(p<0.01)。
- [68Ga]Ga-FAPI-04 PET/MR诊断膈上转移的灵敏度更高,因肝脏SUVmax降低(p<0.001)。
- [68Ga]Ga-FAPI-04 PET/MR在诊断胃肠道侵犯方面可能具有优势。
- 在PCI评分分析中,[68Ga]Ga-FAPI-04 PET/MR可部分纠正[18F]FDG PET/CT遗漏或低估的评分,但左侧肠周转移评分的匹配概率较低且容易高估。
关键数值与推荐
- 根据PCI和SUIDAN评分系统判断不完全切除性。
- 膈肌转移与不完全切除性预测相关性最大(logistic回归 p=0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To provide a theory for guiding clinical treatment by comparing the clinical application value of [18F]fluorodeoxyglucose ([18F]FDG) PET/CT and [68Ga]Ga-FAPI (fibroblast activating protein inhibitor) PET/MR in the diagnosis and evaluation of resectability of ovarian cancer. METHODS: Thirty patients with high clinical suspicion of ovarian malignancies were enrolled from July 2021 to October 2022 and underwent [18F]FDG PET/CT and [68Ga]Ga-FAPI-04 PET/MR within 5 days. Twenty patients underwent [18F]FDG PET/MR at once completing [18F]FDG PET/CT for consistency checking. Images were analysed for comparing SUVs and for judging incomplete resectability according to the peritoneal cancer index (PCI) and SUIDAN scoring system. The expression of FAP, HK2 and Ki67 was analysed by immunohistochemistry staining. RESULTS: There was no significant difference between PET/MR and PET/CT in SUVs-FDG at different locations (p > 0.05), and their diagnostic accuracies were similar. The diagnostic accuracy of [68Ga]Ga-FAPI-04 PET/MR had advantages for peritoneal metastasis since SUVsFAPI were higher (p < 0.01). The sensitivity of [68Ga]Ga-FAPI-04 PET/MR in the diagnosis of peridiaghragmatic metastases was higher because SUVmax in the liver was decreased (p < 0.001). [68Ga]Ga-FAPI-04 PET/MR might have advantages in diagnosing gastrointestinal invasion. In PCI score analysis, [68Ga]Ga-FAPI-04 PET/MR could partially correct missing or underestimated scores by [18F]FDG PET/CT, but the matching probability between left peri-intestinal metastasis scores was low and easy to overestimate. Interestingly, diaphragmatic metastasis detected by [68Ga]Ga-FAPI-04 PET/MR had the greatest correlation with the prediction of incomplete resectability (logistic regression p = 0.02). Through immunohistochemistry, the expression of FAP had a strong correlation with SUVmax-FAPI (p < 0.001), while the expression of HK2 was correlated with SUVmax-FDG (p < 0.01). In addition, SUVmax-FDG with Ki67 ≥ 20% was significantly higher than that with Ki67 < 20% (p < 0.05). CONCLUSIONS: [68Ga]Ga-FAPI-04 PET/MR had obvious advantages for metastases diagnosis and could more accurately assess tumour load and predict incomplete resectability. SUVmax-FDG was conducive to evaluating the degree of tumour malignancy.
引用
- Xi Y, Sun L, Che X, et al. A comparative study of [68Ga]Ga-FAPI-04 PET/MR and [18F]FDG PET/CT in the diagnostic accuracy and resectability prediction of ovarian cancer. Eur J Nucl Med Mol Imaging. 2023. PMID: 37093313. doi:10.1007/s00259-023-06235-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。